Inventor
William H. Romines
Inventor
San Diego, CA, US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds45%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
B22DCasting of metals5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
A61KPreparations for medical, dental or toiletry purposes4%
PatentTitleYear
7,232,912'Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation'20077,045,528'Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use'20066,919,461'Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation'20056,869,962'Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use'20056,833,456'Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use'20046,720,346'Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation'20046,555,539'Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation'20036,525,050'(4-oxo-2-pyrimidinyl)thioalkyl compounds useful as AICARFT inhibitors'20036,323,210'Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds'20016,207,670'Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds'20015,981,748'Synthesis of optically pure compounds useful as GARFT inhibitors and their intermediates'19995,945,427'Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds'19995,831,100'Syntheses of optically pure compounds useful as GARFT inhibitors and their intermediates'19985,739,141'Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds'19985,726,312'Methods for preparing antiproliferative 5-substituted pyrimidone compounds'19985,723,607'Compounds useful as antiproliferative agents and GARFT inhibitors'19985,646,141'Compounds useful as antiproliferative agents and GARFT inhibitors'19975,641,774'Compounds useful as antiproliferative agents and garft inhibitors'19975,641,771'Compounds useful as antiproliferative agents and garft inhibitors'19975,639,747'Compounds useful as antiproliferative agents and garft inhibitors'19975,639,749'Compounds useful as antiproliferative agents and garft inhibitors'19975,625,061'Compounds useful in preparing antiproliferative agents and garft inhibitors'19975,610,319'Compound useful as antiproliferative agents and GARFT inhibitors'19975,608,082'Compounds useful as antiproliferative agents and GARFT inhibitors'19975,594,139'Processes for preparing antiproliferative garft-inhibiting compounds'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2007Patents assigned to AGOURON PHARMA (24)· patent assignee history
1997–2007Based in San Diego, CA, US· patent location history
1998Patents assigned to AGOURON PHARMACETICALS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AGOURON PHARMA | 24 | 1997–2007 |
| AGOURON PHARMACETICALS INC | 1 | 1998 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 25 | 1997–2007 |